{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:38:06Z","timestamp":1792802286847,"version":"4.5.0"},"reference-count":95,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"US National Research Council","id":[{"id":"https:\/\/ror.org\/02eq2w707","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fapem"},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Exxon Mobil Foundation"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral ivermectin is a safe broad spectrum anthelminthic used for treating several neglected tropical diseases (NTDs). Currently, ivermectin use is contraindicated in children weighing less than 15 kg, restricting access to this drug for the treatment of NTDs. Here we provide an updated systematic review of the literature and we conducted an individual-level patient data (IPD) meta-analysis describing the safety of ivermectin in children weighing less than 15 kg.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology\/Principal findings<\/jats:title>\n                    <jats:p>A systematic review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) for IPD guidelines by searching MEDLINE via PubMed, Web of Science, Ovid Embase, LILACS, Cochrane Database of Systematic Reviews, TOXLINE for all clinical trials, case series, case reports, and database entries for reports on the use of ivermectin in children weighing less than 15 kg that were published between 1 January 1980 to 25 October 2019. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO): CRD42017056515. A total of 3,730 publications were identified, 97 were selected for potential inclusion, but only 17 sources describing 15 studies met the minimum criteria which consisted of known weights of children less than 15 kg linked to possible adverse events, and provided comprehensive IPD. A total of 1,088 children weighing less than 15 kg were administered oral ivermectin for one of the following indications: scabies, mass drug administration for scabies control, crusted scabies, cutaneous larva migrans, myiasis, pthiriasis, strongyloidiasis, trichuriasis, and parasitic disease of unknown origin. Overall a total of 1.4% (15\/1,088) of children experienced 18 adverse events all of which were mild and self-limiting. No serious adverse events were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions\/Significance<\/jats:title>\n                    <jats:p>Existing limited data suggest that oral ivermectin in children weighing less than 15 kilograms is safe. Data from well-designed clinical trials are needed to provide further assurance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0009144","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T13:39:16Z","timestamp":1615988356000},"page":"e0009144","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1020-2760","authenticated-orcid":true,"given":"Podjanee","family":"Jittamala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuelton","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3405-6638","authenticated-orcid":true,"given":"Menno R.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Pedrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9812-050X","authenticated-orcid":true,"given":"Carlos J.","family":"Chaccour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-0842","authenticated-orcid":true,"given":"C\u00e9line","family":"Dard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virak","family":"Khieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3734-810X","authenticated-orcid":true,"given":"Annabel","family":"Maruani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-9342","authenticated-orcid":true,"given":"Virgilio E.","family":"Failoc-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4726-2983","authenticated-orcid":true,"given":"Marimar","family":"S\u00e1ez-de-Ocariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-7228","authenticated-orcid":true,"given":"Antoni","family":"Soriano-Arandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-5602","authenticated-orcid":true,"given":"Jaime","family":"Piquero-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Faisant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1366-5856","authenticated-orcid":true,"given":"Marie-Pierre","family":"Brenier-Pinchart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7557-4197","authenticated-orcid":true,"given":"David","family":"Wimmersberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean T.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-3521","authenticated-orcid":true,"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Boralevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sokana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4743","authenticated-orcid":true,"given":"Michael","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-1287","authenticated-orcid":true,"given":"Daniel","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9038-5300","authenticated-orcid":true,"given":"Lucia","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7346-0196","authenticated-orcid":true,"given":"Andrew C.","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0282-6469","authenticated-orcid":true,"given":"Lorenz","family":"von Seidlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1978","authenticated-orcid":true,"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4635-8959","authenticated-orcid":true,"given":"Eli","family":"Harriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1713-6209","authenticated-orcid":true,"given":"Kasia","family":"Stepniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9947-0034","authenticated-orcid":true,"given":"Georgina S.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-0298","authenticated-orcid":true,"given":"Kalynn","family":"Kennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-2963","authenticated-orcid":true,"given":"Philippe J.","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-9681","authenticated-orcid":true,"given":"Kevin C.","family":"Kobylinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"issue":"1","key":"pntd.0009144.ref001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1991.11812534","article-title":"Human onchocerciasis: notes on the history, the parasite and the life cycle","volume":"85","author":"G Nelson","year":"1991","journal-title":"Annals Tropical Medicine Parasitology"},{"issue":"2","key":"pntd.0009144.ref002","first-page":"61","article-title":"The population dynamics of Onchocerca volvulus in the human host","volume":"44","author":"B Duke","year":"1993","journal-title":"Tropical Medicine Parasitology"},{"issue":"42","key":"pntd.0009144.ref003","doi-asserted-by":"crossref","first-page":"15265","DOI":"10.1073\/pnas.0502659102","article-title":"Human infection patterns and heterogeneous exposure in river blindness.","volume":"102","author":"J Filipe","year":"2005","journal-title":"Proceedings National Academy Sciences USA"},{"key":"pntd.0009144.ref004","unstructured":"Mectizan Donation Program. 2019 Annual Highlights Celebrating Milestones & Looking to the Future: Merck & Co., Inc; 2020 [Available from: https:\/\/mectizan.org\/wp-content\/uploads\/2020\/06\/MDP_AH19_051920.pdf."},{"issue":"3\u20134","key":"pntd.0009144.ref005","first-page":"361","article-title":"Ivermectin dose assessment without weighing scales","volume":"71","author":"N Alexander","year":"1993","journal-title":"Bulletin of the World Health Organization"},{"key":"pntd.0009144.ref006","volume-title":"WHO Child Growth Standards: Length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development.","author":"WHO Multicentre Growth Reference Study Group","year":"2006"},{"issue":"2","key":"pntd.0009144.ref007","doi-asserted-by":"crossref","first-page":"e0005201","DOI":"10.1371\/journal.pntd.0005201","article-title":"Nakalanga Syndrome: Clinical Characteristics, Potential Causes, and Its Relationship with Recently Described Nodding Syndrome.","volume":"11","author":"K F\u00f6ger","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0009144.ref008","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2230.2005.01832.x","article-title":"Nodular scabies mimicking urticaria pigmentosa in an infant","volume":"30","author":"C Maule\u00f3n-Fern\u00e1ndez","year":"2005","journal-title":"Clinical and Experimental Dermatology"},{"issue":"4","key":"pntd.0009144.ref009","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/bjd.18369","article-title":"Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study","volume":"182","author":"M Levy","year":"2020","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"pntd.0009144.ref010","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/bjd.12454","article-title":"Treatment of scabies with oral ivermectin in 15 infants: a retrospective study on tolerance and efficacy","volume":"169","author":"C B\u00e9court","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"Suppl 1","key":"pntd.0009144.ref011","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1475-2883-2-S1-S8","article-title":"Ivermectin: does P-glycoprotein play a role in neurotoxicity?","volume":"2","author":"G Edwards","year":"2003","journal-title":"Filaria Journal"},{"issue":"8","key":"pntd.0009144.ref012","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","article-title":"Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene","volume":"11","author":"K Mealey","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"1","key":"pntd.0009144.ref013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.2008.01007.x","article-title":"Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice","volume":"32","author":"J Geyer","year":"2009","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"8","key":"pntd.0009144.ref014","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMc1917344","article-title":"Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations","volume":"383","author":"E Baudou","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"pntd.0009144.ref015","first-page":"89","volume-title":"Toxicology","author":"G Lankas","year":"1989"},{"issue":"1","key":"pntd.0009144.ref016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00418-004-0665-1","article-title":"Immunolocalization of tight junction proteins in the adult and developing human brain","volume":"122","author":"D Virgintino","year":"2004","journal-title":"Histochemistry and cell biology"},{"issue":"4","key":"pntd.0009144.ref017","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/pr.2015.119","article-title":"The ontogeny of P-glycoprotein in the developing human blood-brain barrier: implication for opioid toxicity in neonates","volume":"78","author":"J Lam","year":"2015","journal-title":"Pediatric Research"},{"issue":"1","key":"pntd.0009144.ref018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.toxlet.2010.04.025","article-title":"Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat","volume":"197","author":"C Ek","year":"2010","journal-title":"Toxicology Letters"},{"issue":"5","key":"pntd.0009144.ref019","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/archdischild-2017-314505","article-title":"Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?","volume":"103","author":"A Wilkins","year":"2018","journal-title":"Archives of disease in childhood"},{"issue":"16","key":"pntd.0009144.ref020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement","volume":"313","author":"L Stewart","year":"2015","journal-title":"JAMA"},{"key":"pntd.0009144.ref021","article-title":"Part 312 Investigational New Drug Application In: Services DoHaH, editor.:","author":"US Food","year":"2019","journal-title":"Code of Federal Regulations"},{"key":"pntd.0009144.ref022","unstructured":"WorldWide Antimalarial Resistance Network. Clinical Module: Data Management and Statistical Analysis Plan, Version 1.2 2012 [Available from: www.wwarn.org\/sites\/default\/files\/ClinicalDMSAP.pdf."},{"issue":"5","key":"pntd.0009144.ref023","first-page":"356","article-title":"Scabies of the nail unit in an infant.","volume":"144","author":"A Finon","year":"2017","journal-title":"Annales de Dermatologie et de Venereologie."},{"issue":"9","key":"pntd.0009144.ref024","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2340\/00015555-3217","article-title":"Autochthonous Cutaneous Larva Migrans in France and Europe.","volume":"99","author":"P Del Giudice","year":"2019","journal-title":"Acta Dermato-Venereologica."},{"issue":"4","key":"pntd.0009144.ref025","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1111\/jdv.15356","article-title":"Autochthonous and persistent cutaneous larva migrans in an infant successfully treated by topic albendazole ointment","volume":"33","author":"M Robert","year":"2019","journal-title":"Journal of the European Academy of Dermatology Venereology"},{"issue":"17","key":"pntd.0009144.ref026","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMc1210168","article-title":"Case 23\u20132012: A man with abdominal pain and weight loss","volume":"367","author":"C Chaccour","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"pntd.0009144.ref027","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpeds.2019.02.002","article-title":"Crusts on the Eyelashes","volume":"209","author":"M Ouedraogo","year":"2019","journal-title":"The Journal of Pediatrics"},{"issue":"3","key":"pntd.0009144.ref028","first-page":"136","article-title":"Crusted scabies in cushingoid child treated with oral ivermectin.","volume":"8","author":"J Piquero-Casals","year":"2002","journal-title":"Dermatologia Argentina"},{"issue":"10","key":"pntd.0009144.ref029","doi-asserted-by":"crossref","first-page":"e3040","DOI":"10.1097\/MD.0000000000003040","article-title":"Discordances Between Serology and Culture for Strongyloides in an Ethiopian Adopted Child With Multiple Parasitic Infections: A Case Report.","volume":"95","author":"A Soriano-Arandes","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"1","key":"pntd.0009144.ref030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4269\/ajtmh.16-0437","article-title":"Case Report: Myiasis due to Cochliomyia hominivorax and Dermatobia hominis: Clinical and Pathological Differences between Two Species in Northern Peru","volume":"98","author":"V Failoc-Rojas","year":"2018","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"4","key":"pntd.0009144.ref031","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2230.2002.01050.x","article-title":"Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin","volume":"27","author":"M S\u00e1ez-de-Ocariz","year":"2002","journal-title":"Clinical and Experimental Dermatology"},{"issue":"3","key":"pntd.0009144.ref032","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4269\/ajtmh.16-0792","article-title":"First Evidence of Angiostrongyliasis Caused by Angiostrongylus cantonensis in Guadeloupe, Lesser Antilles","volume":"96","author":"C Dard","year":"2017","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"8","key":"pntd.0009144.ref033","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/cid\/ciy246","article-title":"Efficacy and Safety of Ivermectin Against Trichuris trichiura in Preschool-aged and School-aged Children: A Randomized Controlled Dose-finding Trial","volume":"67","author":"D Wimmersberger","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"pntd.0009144.ref034","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1016\/S2214-109X(18)30397-8","article-title":"Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial","volume":"6","author":"L Romani","year":"2018","journal-title":"Lancet Global Health"},{"issue":"8","key":"pntd.0009144.ref035","doi-asserted-by":"crossref","first-page":"e0004909","DOI":"10.1371\/journal.pntd.0004909","article-title":"Ivermectin Treatment and Sanitation Effectively Reduce Strongyloides stercoralis Infection Risk in Rural Communities in Cambodia.","volume":"10","author":"A Forrer","year":"2016","journal-title":"PLoS Neglected Tropical Diseases."},{"issue":"10","key":"pntd.0009144.ref036","doi-asserted-by":"crossref","first-page":"e0005685","DOI":"10.1371\/journal.pntd.0005685","article-title":"Strongyloides stercoralis is associated with significant morbidity in rural Cambodia, including stunting in children.","volume":"11","author":"A Forrer","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0009144.ref037","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jpeds.2018.01.038","article-title":"Prevalence of Nail Scabies: A French Prospective Multicenter Study","volume":"197","author":"M Chinazzo","year":"2018","journal-title":"The Journal of Pediatrics"},{"key":"pntd.0009144.ref038","unstructured":"Merck Sharp & Dohme (France). Mectizan Package Insert. 2014."},{"key":"pntd.0009144.ref039","unstructured":"Merck Sharp & Dohme (Australia). Stromectol Package Insert. 2014."},{"issue":"24","key":"pntd.0009144.ref040","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass Drug Administration for Scabies Control in a Population with Endemic Disease","volume":"373","author":"L Romani","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"12","key":"pntd.0009144.ref041","doi-asserted-by":"crossref","first-page":"e0004246","DOI":"10.1371\/journal.pntd.0004246","article-title":"Long Term Control of Scabies Fifteen Years after an Intensive Treatment Programme.","volume":"9","author":"M Marks","year":"2015","journal-title":"PLoS Neglected Tropical Diseases."},{"issue":"6.1","key":"pntd.0009144.ref042","doi-asserted-by":"crossref","first-page":"28s","DOI":"10.3855\/jidc.11701","article-title":"\"Stopping the itch\": mass drug administration for scabies outbreak control covered for over nine million people in Ethiopia.","volume":"14","author":"W Enbiale","year":"2020","journal-title":"The Journal of Infection in Developing Countries"},{"issue":"6","key":"pntd.0009144.ref043","first-page":"670","article-title":"Treatment of scabies and Ascabiol supply disruption: what about the pediatric population?","volume":"21","author":"A Berthe-Aucejo","year":"2014","journal-title":"Archives de Pediatrie"},{"issue":"5","key":"pntd.0009144.ref044","first-page":"341","article-title":"Evaluation of practices in the management of scabies in children.","volume":"144","author":"M L\u00ea","year":"2017","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"4","key":"pntd.0009144.ref045","doi-asserted-by":"crossref","first-page":"e0006458","DOI":"10.1371\/journal.pntd.0006458","article-title":"Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis.","volume":"12","author":"M Palmeirim","year":"2018","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0009144.ref046","unstructured":"World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2015. Weekly Epidemiology Record. 2016;39(91):441\u201360."},{"key":"pntd.0009144.ref047","volume-title":"Model List of Essential Medicines for Children, 7th List.","author":"World Health Organization","year":"2019"},{"issue":"9","key":"pntd.0009144.ref048","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0169-4758(99)01486-6","article-title":"The role of albendazole in programmes to eliminate lymphatic filariasis","volume":"15","author":"E Ottesen","year":"1999","journal-title":"Parasitology Today"},{"issue":"6","key":"pntd.0009144.ref049","doi-asserted-by":"crossref","first-page":"e1002839","DOI":"10.1371\/journal.pmed.1002839","article-title":"The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.","volume":"16","author":"G Weil","year":"2019","journal-title":"PLoS medicine."},{"key":"pntd.0009144.ref050","unstructured":"Merck. Program expanded to reach additional 100 million people annually for lymphatic filariasis in support of new, evidence-based WHO guidelines Merck Newsroom Home2017 [Available from: https:\/\/www.mrknewsroom.com\/news-release\/corporate-news\/merck-commemorates-30-years-mectizan-donation-program-progress."},{"issue":"4","key":"pntd.0009144.ref051","first-page":"681","article-title":"The effect of ivermectin on geohelminth frequency (i.e. as used in the onchocerciasis control program in Colombia).","volume":"14","author":"A Knudson","year":"2012","journal-title":"Revista de Salud Publica (Bogota, Colombia)."},{"issue":"11","key":"pntd.0009144.ref052","doi-asserted-by":"crossref","first-page":"e0004150","DOI":"10.1371\/journal.pntd.0004150","article-title":"Mass administration of ivermectin for the elimination of Onchocerciasis significantly reduced and maintained low the prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.","volume":"9","author":"M Anselmi","year":"2015","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"10","key":"pntd.0009144.ref053","doi-asserted-by":"crossref","first-page":"e0006003","DOI":"10.1371\/journal.pntd.0006003","article-title":"Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.","volume":"11","author":"A Echazu","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"5","key":"pntd.0009144.ref054","doi-asserted-by":"crossref","first-page":"e0005607","DOI":"10.1371\/journal.pntd.0005607","article-title":"Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community.","volume":"11","author":"T Kearns","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"1","key":"pntd.0009144.ref055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7705\/biomedica.v24i1.1246","article-title":"Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis.","volume":"24","author":"L Ord\u00f3\u00f1ez","year":"2004","journal-title":"Biomedica"},{"issue":"6","key":"pntd.0009144.ref056","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/507038","article-title":"Role of ivermectin in the treatment of severe orbital myiasis due to Cochliomyia hominivorax","volume":"43","author":"J Osorio","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"1\u20133","key":"pntd.0009144.ref057","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-5876(93)90045-5","article-title":"Myiasis in children: the Indian perspective","volume":"25","author":"I Singh","year":"1993","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"issue":"Suppl 1","key":"pntd.0009144.ref058","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.4103\/0976-237X.95097","article-title":"Oral myiasis in children.","volume":"3","author":"M Reddy","year":"2012","journal-title":"Contemporary Clinical Dentistry"},{"issue":"1","key":"pntd.0009144.ref059","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/ICB.0b013e318208859c","article-title":"Successful treatment of ophthalmomyiasis interna posterior with ivermectin.","volume":"6","author":"K Taba","year":"2012","journal-title":"Retinal Cases & Brief Reports."},{"issue":"25","key":"pntd.0009144.ref060","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMc1201434","article-title":"Dermal swellings and ocular injury after exposure to reindeer","volume":"367","author":"B Kan","year":"2012","journal-title":"N Engl J Med"},{"issue":"29","key":"pntd.0009144.ref061","article-title":"Human myiasis caused by the reindeer warble fly, Hypoderma tarandi, case series from Norway, 2011 to 2016.","volume":"22","author":"J Landehag","year":"2017","journal-title":"Euro Surveillance."},{"issue":"2","key":"pntd.0009144.ref062","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1620\/tjem.206.125","article-title":"Aural myiasis in children and literature review","volume":"206","author":"K Yuca","year":"2005","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"26\u201328","key":"pntd.0009144.ref063","first-page":"1694","article-title":"Suspected lice eggs in the hair of a boy revealed dangerous parasite.","volume":"107","author":"B Kan","year":"2010","journal-title":"Lakartidningen"},{"key":"pntd.0009144.ref064","volume-title":"The global burden of onchocerciasis in 1990","author":"J Remme","year":"2004"},{"key":"pntd.0009144.ref065","volume-title":"Importance of oncho skin disease. Report of a multicountry study","author":"World Health Organization","year":"1995"},{"issue":"7","key":"pntd.0009144.ref066","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0277-9536(98)00007-0","article-title":"Stigma associated with onchocercal skin disease among those affected near the Ofiki and Oyan Rivers in western Nigeria","volume":"47","author":"W Brieger","year":"1998","journal-title":"Social Science and Medicine"},{"issue":"3","key":"pntd.0009144.ref067","doi-asserted-by":"crossref","first-page":"e1578","DOI":"10.1371\/journal.pntd.0001578","article-title":"Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality.","volume":"6","author":"M Walker","year":"2012","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"12","key":"pntd.0009144.ref068","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1528-1167.2008.01671.x","article-title":"The head nodding syndrome\u2014clinical classification and possible causes","volume":"49","author":"A Winkler","year":"2008","journal-title":"Epilepsia"},{"issue":"10","key":"pntd.0009144.ref069","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/j.1528-1167.2009.02280.x","article-title":"Head nodding syndrome and river blindness: a parasitologic perspective","volume":"50","author":"C Kaiser","year":"2009","journal-title":"Epilepsia"},{"issue":"3","key":"pntd.0009144.ref070","doi-asserted-by":"crossref","first-page":"e2147","DOI":"10.1371\/journal.pntd.0002147","article-title":"Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.","volume":"7","author":"C Kaiser","year":"2013","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"6","key":"pntd.0009144.ref071","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1371\/journal.pntd.0000461","article-title":"Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys.","volume":"3","author":"SD Pion","year":"2009","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"11","key":"pntd.0009144.ref072","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S1473-3099(18)30425-0","article-title":"The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study","volume":"18","author":"C Chesnais","year":"2018","journal-title":"Lancet Infectious Diseases"},{"issue":"6","key":"pntd.0009144.ref073","doi-asserted-by":"crossref","first-page":"ofaa206","DOI":"10.1093\/ofid\/ofaa206","article-title":"A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy","volume":"7","author":"C Chesnais","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"377","key":"pntd.0009144.ref074","doi-asserted-by":"crossref","first-page":"e6953","DOI":"10.1126\/scitranslmed.aaf6953","article-title":"Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus","volume":"9","author":"T Johnson","year":"2017","journal-title":"Science Translational Medicine"},{"issue":"2","key":"pntd.0009144.ref075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/epi4.12054","article-title":"Onchocerciasis-associated epilepsy: From recent epidemiological and clinical findings to policy implications","volume":"2","author":"R Colebunders","year":"2017","journal-title":"Epilepsia Open"},{"issue":"7","key":"pntd.0009144.ref076","doi-asserted-by":"crossref","first-page":"e0005732","DOI":"10.1371\/journal.pntd.0005732","article-title":"High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.","volume":"11","author":"B Levick","year":"2017","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"pntd.0009144.ref077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2016.05.018","article-title":"Risk factors for epilepsy in Bas-Uele Province, Democratic Republic of the Congo: a case-control study","volume":"49","author":"R Colebunders","year":"2016","journal-title":"International Journal of Infectious Diseases"},{"issue":"11","key":"pntd.0009144.ref078","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S1473-3099(20)30122-5","article-title":"Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies","volume":"20","author":"N Gumisiriza","year":"2020","journal-title":"Lancet Infect Diseases."},{"issue":"1","key":"pntd.0009144.ref079","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40249-020-0628-3","article-title":"Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.","volume":"9","author":"N Gumisiriza","year":"2020","journal-title":"Infectious Diseases of Poverty"},{"issue":"1","key":"pntd.0009144.ref080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","article-title":"Short Report: Ivermectin Mass Drug Administration to Humans Disrupts Malaria Parasite Transmission in Senegalese Villages","volume":"85","author":"K Kobylinski","year":"2011","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"pntd.0009144.ref081","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1186\/1475-2875-13-417","article-title":"Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments","volume":"13","author":"H Alout","year":"2014","journal-title":"Malaria Journal"},{"issue":"10180","key":"pntd.0009144.ref082","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(18)32321-3","article-title":"Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial.","volume":"393","author":"B Foy","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"pntd.0009144.ref083","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/infdis\/jiu351","article-title":"The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study","volume":"210","author":"H Slater","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"pntd.0009144.ref084","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cid\/ciu797","article-title":"Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: A double-blind, randomized, clinical trial","volume":"60","author":"A Ou\u00e9draogo","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"pntd.0009144.ref085","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1473-3099(18)30163-4","article-title":"Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.","volume":"18","author":"M Smit","year":"2018","journal-title":"Lancet Infectious Diseases"},{"issue":"5","key":"pntd.0009144.ref086","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cpt.1716","article-title":"Safety, pharmacokinetics, and mosquito-lethal effects of ivermectin in combination with dihydroartemisinin-piperaquine and primaquine in healthy adult","volume":"107","author":"K Kobylinski","year":"2020","journal-title":"Thai subjects Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"pntd.0009144.ref087","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(19)30633-4","article-title":"Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study","volume":"20","author":"H Slater","year":"2020","journal-title":"Lancet Infect Dis."},{"issue":"2","key":"pntd.0009144.ref088","doi-asserted-by":"crossref","first-page":"e02005","DOI":"10.1128\/AAC.02005-16","article-title":"Inhibition of Plasmodium Liver Infection by Ivermectin","volume":"61","author":"AM Mendes","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"pntd.0009144.ref089","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/tmi.13357","article-title":"Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial","volume":"25","author":"W Metzger","year":"2020","journal-title":"Tropical Medicine and International Health"},{"key":"pntd.0009144.ref090","first-page":"99","article-title":"Pediculosis capitis: Tratamiento de 100 ni\u00f1os con Ivermectina.","volume":"20","author":"V Jairo","year":"1997","journal-title":"Act Terap Dermatol."},{"key":"pntd.0009144.ref091","first-page":"448","article-title":"Ivermectina en pediculosis capitis.","volume":"21","author":"V Jairo","year":"1998","journal-title":"Act Terap Dermatol"},{"issue":"1","key":"pntd.0009144.ref092","first-page":"61","article-title":"Uso de Ivermectina en ninos.","volume":"1","author":"V Jairo","year":"2003","journal-title":"Dermatologia Pedi\u00e1trica Latinoamericana"},{"issue":"6","key":"pntd.0009144.ref093","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/jac\/dkz083","article-title":"Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2\u201312 years","volume":"74","author":"J Schulz","year":"2019","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"pntd.0009144.ref094","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/cpt.1456","article-title":"Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults","volume":"106","author":"J Brussee","year":"2019","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"pntd.0009144.ref095","volume-title":"Ivermectin Safety in Small Children (NCT04332068).","author":"K Kobylinski","year":"2020"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011053","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T01:20:15Z","timestamp":1724635215000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009144"}},"subtitle":[],"editor":[{"given":"Jennifer A.","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":95,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009144","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]}}}